<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
{
Book a Demo
    January 12, 2016

    Top Ten Reasons for Biotechs to Acquire CDD Vault

    Top Ten Reasons for Biotechs to Acquire CDD Vault

    1. Scientists may come and go, but data live on
    2. Encourage project scientists to follow healthy data management practices
    3. Enhance research workflows
    4. Improve acquisition and analysis of project data
    5. Serve all members of the project team
    6. Promote research collaborations
    7. Enhance structure-activity analyses
    8. Protect New Leads and other IP value
    9. Scientists can focus on science, not maintaining datasystems
    10. A complete, cloud-based solution reduces both capital outlays and manpower costs

     

    1. Scientists may come and go, but data live on

    • Scientific advances may mandate review or reanalysis of data from previous projects
    • Updates are difficult from scattered and poorly documented project data
    • Project scientists know their data, but more context is needed for archived datastores

     

    2. Encourage project scientists to follow healthy data management practices

    • CDDVault project templates create complete and accurate project datasets
    • Templates and calculations are easily customized for project scientists' needs
    • Data analyses and sharing – generation of routine reports are more efficiently managed

     

    3. Enhance research workflows

    • All members of the project team can enter, analyze, report their data – in the same database!
    • Project managers can more easily track progress, identify bottlenecks, pivot to new leads
    • Hand-offs from one group to another are more easily tracked and followed up

     

    4. Improve acquisition and analysis of project data

    • Registration and submission of samples, sample tracking, assay registration, data analysis, result summary, posting, report creation – are all performed in one comprehensive system
    • Results may be analyzed with included tools or CDDVision, or by linking to other analysis programs

     

    5. Serve all members of the project team

    • CDDVault handles data from medicinal chemistry, analytical chemistry, experimental biology, molecular biology, toxicology, computational chemistry, and other project team disciplines
    • Chemists can look at raw plus calculated assay results, study a lead compound class's bioprofile
    • Biologists can see ancillary compound data – chemical type, stability, solubility, therapeutic window

     

    6. Promote research collaborations

    • External and internal collaborators can see and manipulate appropriate data
    • Data from multiple external collaborations can easily be manipulated, partitioned, or integrated

     

    7. Enhance structure-activity analyses

    • Chemists can compute/correlate structures/properties/activities and propose hypotheses
    • Biologists can search for similar compounds and properties in public databases
    • Structure-activity, structure-property, and sequence-property correlations may be explored

     

    8. Protect New Leads and other IP value

    • Missing or poorly documented data can sink a patent application or licensing deal
    • A proper database is required to ensure datasets are auditable, and data changes are tracked

     

    9. Scientists can focus on science, not maintaining datasystems

    • Scientist-created and -maintained datastores may cause problems and take time away from research
    • Bespoke database solutions may require significant IT support to meet scientists' changing needs

     

    10. A complete, cloud-based solution reduces both capital outlays and manpower costs

    • In-house solutions require hardware and software purchases, ongoing programmer commitments, and periodic upgrades
    • Cloud-based CDDVault handles system maintenance, security, backup, and necessary upgrades as a fixed, agreed-on cost

     

    From the desk of Peter Gund, CDD Advocate

    Other posts you might be interested in

    View All Posts
    News
    2 min   November 20, 2024
    Collaborative Drug Discovery Receives SOC 2 Type II Compliance Attestation
    Read More
    CDD Blog
    8 min   November 19, 2024
    Drug Discovery Industry Roundup with Barry Bunin — November, 19 2024
    Read More
    CDD Vault Snack
    4 min   November 18, 2024
    Vault Snack #25 - All About CDD Vault Templates
    Read More